Voyager Limited Liability Company
Mark Levin is the chairman of Voyager’s board of directors and a partner at Third Rock Ventures. He is an industry visionary with 40 years of experience, including more than 30 years launching and building leading biotech companies. Mr. Levin co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of its portfolio companies, as well as actively identifying and evaluating new investments. Prior to Third Rock, Mr. Levin was co-founder of Mayfield Fund’s life sciences effort, where he was also the founding CEO of Tularik, Cell Genesys/Abgenix, Focal, Stem Cells and Millennium Pharmaceuticals. Mr. Levin served as CEO of Millennium Pharmaceuticals for 12 years. Earlier in his career, he was an engineer and project leader at Eli Lilly and Genentech. He is a member of the National Academy of Engineering and the Friends of Personalized Medicine, and he co-founded the Possible Project in Cambridge, Mass.